Hostname: page-component-77c89778f8-swr86 Total loading time: 0 Render date: 2024-07-22T17:22:06.237Z Has data issue: false hasContentIssue false
  • English
  • Français

Cost-effectiveness thresholds: a comment on the commentaries

Published online by Cambridge University Press:  02 March 2016

Anthony J. Culyer
Anthony J. Culyer*
Affiliation:
Institute of Health Policy Management and Evaluation, University of Toronto, Ontario, Canada Centre for Health Economics, University of York, York, England
*
*Correspondence to: Anthony Culyer, University of Toronto, Health Sciences Building, 155 College Street, Suite 425, Toronto, ON, Canada, M5T 3M6. Email: tony.culyer@utoronto.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Debate
Information
Health Economics, Policy and Law , Volume 11 , Issue 4 , October 2016 , pp. 445 - 447
Check for updates
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Claxton, K., Sculpher, M., Palmer, S. and Culyer, A. J. (2015), ‘Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?’, Health Economics, 24: 1–7.Google Scholar
Cookson, R. A. and Claxton, K. (eds) (2012), The Humble Economist: Tony Culyer on Health, Health Care and Social Decision Making, London and York: Office of Health Economics and University of York.Google Scholar
Culyer, A. J. (2010), ‘Perspective and desire in comparative effectiveness research – the relative unimportance of mere preferences, the central importance of context’, PharmacoEconomics, 28: 889–897.CrossRefGoogle ScholarPubMed
Culyer, A. J. (2014), ‘Are There Really Ten Good Arguments for a Societal Perspective in the Economic Evaluations of Medical Innovations?’, in A. J. Culyer and G. Kobelt (eds), Portrait of a Health Economist: Festschrift in Honour of Bengt Jönsson, Lund: Institute of Health Economics, 33–38.Google Scholar
Culyer, A. J. (2016a), ‘Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use’, Health Economics, Policy and Law (this issue).CrossRefGoogle Scholar
Culyer, A. J. (2016b), ‘Equality and Equity’, in H. ten Have (ed.) The Encyclopaedia of Global Bioethics, New York: Springer, 1–11.Google Scholar
McCabe, C., Paulden, M., O’Mahony, J. F., Edlin, R. and Culyer, A. J. (2015), ‘Life at a premium: considering an end-of-life premium in value-based reimbursement’, Value in Health, 18: A6–A7.Google Scholar
Paprica, P. A., Culyer, A. J., Eshag, A. G., Peffer, J. and Sandoval, G. A. (2015), ‘From talk to action: policy stakeholders, appropriateness, and selective disinvestment’, International Journal of Technology Assessment in Health Care, 31: 1–5.Google Scholar
Sen, A. K. (1993), ‘Capability and Well-Being’, in: M. C. Nussbaum and A. K. Sen, (eds), The Quality of Life, Oxford: Clarendon Press.Google Scholar